本页面由Tiger Trade Technology Pte. Ltd.提供服务

Emergent Biosolutions

5.18
+0.10001.97%
盘后5.210.0300+0.58%18:02 EDT
成交量:87.11万
成交额:448.01万
市值:2.66亿
市盈率:-1.53
高:5.22
开:5.02
低:5.00
收:5.08
52周最高:14.06
52周最低:4.36
股本:5,127.33万
流通股本:4,837.27万
量比:0.73
换手率:1.80%
股息:- -
股息率:- -
每股收益(TTM):-3.3870
每股收益(LYR):0.9300
净资产收益率:-40.29%
总资产收益率:6.93%
市净率:0.78
市盈率(LYR):5.57

数据加载中...

2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/31

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/29

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/29

重要事件披露

Form 8-K - Current report
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/17

重要事件披露

Form 8-K - Current report
2026/04/10

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

重要事件披露

Form 8-K - Current report